| Global epigenomic reconfiguration during mammalian brain development R Lister, EA Mukamel, JR Nery, M Urich, CA Puddifoot, ND Johnson, ... Science 341 (6146), 1237905, 2013 | 2015 | 2013 |
| Chemically defined generation of human cardiomyocytes PW Burridge, E Matsa, P Shukla, ZC Lin, JM Churko, AD Ebert, F Lan, ... Nature methods 11 (8), 855-860, 2014 | 1756 | 2014 |
| Induced pluripotent stem cell technology: a decade of progress Y Shi, H Inoue, JC Wu, S Yamanaka Nature reviews Drug discovery 16 (2), 115-130, 2017 | 1608 | 2017 |
| COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives M Nishiga, DW Wang, Y Han, DB Lewis, JC Wu Nature Reviews Cardiology 17 (9), 543-558, 2020 | 1567 | 2020 |
| Amygdala activity at encoding correlated with long-term, free recall of emotional information. L Cahill, RJ Haier, J Fallon, MT Alkire, C Tang, D Keator, J Wu, ... Proceedings of the National Academy of sciences 93 (15), 8016-8021, 1996 | 1426 | 1996 |
| A nonviral minicircle vector for deriving human iPS cells F Jia, KD Wilson, N Sun, DM Gupta, M Huang, Z Li, NJ Panetta, ZY Chen, ... Nature methods 7 (3), 197-199, 2010 | 968 | 2010 |
| Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming PW Burridge, G Keller, JD Gold, JC Wu Cell stem cell 10 (1), 16-28, 2012 | 815 | 2012 |
| Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy N Sun, M Yazawa, J Liu, L Han, V Sanchez-Freire, OJ Abilez, ... Science translational medicine 4 (130), 130ra47-130ra47, 2012 | 799 | 2012 |
| Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies AS Lee, C Tang, MS Rao, IL Weissman, JC Wu Nature medicine 19 (8), 998-1004, 2013 | 785 | 2013 |
| Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells F Lan, AS Lee, P Liang, V Sanchez-Freire, PK Nguyen, L Wang, L Han, ... Cell stem cell 12 (1), 101-113, 2013 | 764 | 2013 |
| Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ... Nature medicine 22 (5), 547-556, 2016 | 740 | 2016 |
| Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells N Sun, NJ Panetta, DM Gupta, KD Wilson, A Lee, F Jia, S Hu, AM Cherry, ... Proceedings of the National Academy of Sciences 106 (37), 15720-15725, 2009 | 690 | 2009 |
| Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis RC Wirka, D Wagh, DT Paik, M Pjanic, T Nguyen, CL Miller, R Kundu, ... Nature medicine 25 (8), 1280-1289, 2019 | 674 | 2019 |
| In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery F Cao, S Lin, X Xie, P Ray, M Patel, X Zhang, M Drukker, SJ Dylla, ... Circulation 113 (7), 1005-1014, 2006 | 654 | 2006 |
| Drug screening using a library of human induced pluripotent stem cell–derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity P Liang, F Lan, AS Lee, T Gong, V Sanchez-Freire, Y Wang, S Diecke, ... Circulation 127 (16), 1677-1691, 2013 | 639 | 2013 |
| Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair M Tiburcy, JE Hudson, P Balfanz, S Schlick, T Meyer, ML Chang Liao, ... Circulation 135 (19), 1832-1847, 2017 | 629 | 2017 |
| MicroRNA-210 as a novel therapy for treatment of ischemic heart disease S Hu, M Huang, Z Li, F Jia, Z Ghosh, MA Lijkwan, P Fasanaro, N Sun, ... Circulation 122 (11_suppl_1), S124-S131, 2010 | 555 | 2010 |
| Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes I Karakikes, M Ameen, V Termglinchan, JC Wu Circulation research 117 (1), 80-88, 2015 | 551 | 2015 |
| An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells C Tang, AS Lee, JP Volkmer, D Sahoo, D Nag, AR Mosley, MA Inlay, ... Nature biotechnology 29 (9), 829-834, 2011 | 450 | 2011 |
| High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells A Sharma, PW Burridge, WL McKeithan, R Serrano, P Shukla, N Sayed, ... Science translational medicine 9 (377), eaaf2584, 2017 | 385 | 2017 |
Sanjiv S. GambhirProfessor of Radiology, Stanford UniversityVerifisert e-postadresse på stanford.edu
